Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Rank in Stocks #17923
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Share Price
$18.20
Last synced: 2025-05-09
Market Cap
$220.35M
Change (1 day)
-5.34%
Change (1 year)
0.00%
Country
JP
Trade I'rom Group Co., Ltd. (2372)

Category

Earnings for I'rom Group Co., Ltd. (2372)
Earnings in Dec 2024 TTM: $9.98M
According to I'rom Group Co., Ltd. latest financial reports the company's current earnings are $9.98M. In 2023 the company made an earning of $25.17M, an increase over its 2022 earnings that were of $21.24M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for I'rom Group Co., Ltd. from 2005 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $9.98M -23.16%
2024 $12.99M -48.39%
2023 $25.17M 18.51%
2022 $21.24M 39.44%
2021 $15.23M 45.30%
2020 $10.48M -1.23%
2019 $10.61M -38.18%
2018 $17.17M 595.33%
2017 $2.47M -134.25%
2016 $-7.21M 43.61%
2015 $-5.02M 55.00%
2014 $-3.24M -117.10%
2013 $18.94M -1,247.10%
2012 $-1.65M -227.92%
2011 $1.29M -117.79%
2010 $-7.26M -93.02%
2009 $-104.01M 912.86%
2008 $-10.27M 79.68%
2007 $-5.72M -184.52%
2006 $6.76M -56.10%
2005 $15.40M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$9.87B 98,800.88%
US
- -
DE
$687.82M 6,791.50%
SA
$3.87B 38,624.74%
US
- -
MY